Regulation 76A Amendment of regulation 67 (failure to place on the market etc.)F1I1
(1)
Regulation 67 (failure to place on the market etc.) is amended as follows.
(2)
In paragraph (1) after “in the United Kingdom” insert “(or, in the case of a UKMA(GB) granted after an application under the unfettered access route, in Great Britain)”.
(3)
In paragraph (2) after “in the United Kingdom” insert “(or, in the case of a UKMA(GB) granted after an application under the unfettered access route, in Great Britain)”.
Annotations
Textual amendments
- F1
Reg. 76A inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 56
Commencement
- I1
Reg. 76A in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1